Skip to main content
Log in

Influenza vaccination for children beneficial to society

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Navas E, Salleras L, Domínguez A, Ibáñez D, Prat A, Sentís J, Garrido P.Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 25: 3233-3239, No. 16, 20 Apr 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Influenza vaccination for children beneficial to society. Pharmacoecon. Outcomes News 529, 9 (2007). https://doi.org/10.2165/00151234-200705290-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00022

Keywords

Navigation